PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 176 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,841 | -25.5% | 32,639 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $115,216 | +16.9% | 32,639 | +2.4% | 0.01% | 0.0% |
| Q1 2023 | $98,522 | -18.3% | 31,884 | +11.9% | 0.01% | -33.3% |
| Q4 2022 | $120,538 | +79.9% | 28,496 | +1.0% | 0.02% | +100.0% |
| Q3 2022 | $67,000 | -16.2% | 28,205 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $80,000 | -2.4% | 28,205 | -1.3% | 0.01% | 0.0% |
| Q1 2022 | $82,000 | -79.9% | 28,571 | -10.7% | 0.01% | -81.8% |
| Q2 2019 | $407,000 | -62.1% | 32,000 | +76.5% | 0.06% | -51.3% |
| Q2 2018 | $1,073,000 | -21.7% | 18,132 | +15.6% | 0.11% | -38.6% |
| Q2 2017 | $1,371,000 | +185.6% | 15,685 | +21.6% | 0.18% | +109.1% |
| Q1 2017 | $480,000 | – | 12,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |